Intech Investment Management LLC Purchases 57,892 Shares of UnitedHealth Group Incorporated $UNH

Intech Investment Management LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 28.7% during the 2nd quarter, HoldingsChannel reports. The firm owned 259,851 shares of the healthcare conglomerate’s stock after acquiring an additional 57,892 shares during the quarter. UnitedHealth Group comprises about 0.8% of Intech Investment Management LLC’s investment portfolio, making the stock its 17th biggest position. Intech Investment Management LLC’s holdings in UnitedHealth Group were worth $81,066,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the business. Nuveen LLC bought a new position in UnitedHealth Group during the first quarter worth $3,846,764,000. Vanguard Group Inc. raised its position in shares of UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after buying an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP grew its position in UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after buying an additional 2,486,839 shares in the last quarter. Davis Selected Advisers lifted its position in UnitedHealth Group by 2,234.9% in the second quarter. Davis Selected Advisers now owns 1,132,885 shares of the healthcare conglomerate’s stock worth $353,426,000 after purchasing an additional 1,084,366 shares during the period. Finally, National Bank of Canada FI raised its stake in shares of UnitedHealth Group by 137.8% in the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock valued at $859,518,000 after buying an additional 950,928 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE UNH opened at $321.44 on Friday. The firm has a market capitalization of $291.17 billion, a P/E ratio of 16.78, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The firm’s fifty day moving average price is $347.65 and its two-hundred day moving average price is $320.06. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $622.83. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. During the same period last year, the business posted $7.15 EPS. UnitedHealth Group’s revenue was up 12.2% on a year-over-year basis. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on UNH. Truist Financial raised their price target on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. Jefferies Financial Group raised their price target on shares of UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a report on Friday, October 17th. Mizuho raised their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Finally, Leerink Partners set a $410.00 target price on UnitedHealth Group and gave the company an “outperform” rating in a research note on Wednesday, October 29th. Eighteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.